Research programme: trophic factor biotherapeutics - MesoblastAlternative Names: Cytokine biotherapeutics - Mesoblast; SDF-1 - Mesoblast; Stromal derived factor-1 - Mesoblast
Latest Information Update: 05 Feb 2014
At a glance
- Originator Mesoblast
- Class CXC chemokines; Peptides; Small molecules
- Mechanism of Action Angiogenesis inducing agents; CXCR4 receptor agonists; Leukocyte stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cardiovascular disorders
Most Recent Events
- 29 Jan 2014 Preclinical trials in Cardiovascular disorders in Australia (unspecified route)